Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. - Archive ouverte HAL Access content directly
Journal Articles NMR in Biomedicine Year : 2007

Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.

(1) , (2, 3) , (2, 3) , (4) , (1) , (5) , (1) , (1) , (1) , (2, 3)
1
2
3
4
5

Abstract

Loss of nigral dopamine neurons in Parkinson's disease induces abnormal activation of glutamate systems in the basal ganglia. The purpose of this study was to assess these changes in the lentiform nucleus using MRS with optimized glutamate sensitivity (TE-averaged method). Ten patients with Parkinson's disease and 10 healthy controls were examined. Compared with healthy controls, no significant differences in glutamate were measured in patients, but a trend to lower total creatine was observed.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-00381742 , version 1 (17-08-2009)

Identifiers

Cite

Nils Kickler, Paul Krack, Valérie Fraix, Jean-François Lebas, Laurent Lamalle, et al.. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.. NMR in Biomedicine, 2007, 20 (8), pp.757-62. ⟨10.1002/nbm.1141⟩. ⟨inserm-00381742⟩
93 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More